Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- Boulogne-Billancourt, FranceSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 24 Aug 2022
- Planned end
- Apr 2026
- Type of study
- Observational
- Record updated
- 19 March 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show the criterionShow less
Who cannot take part
- -
Where in France
- Rhumatology department, Ambroise Paré hospital - APHPBoulogne-Billancourt, FranceContact: Maria-Antonietta D'AGOSTINO, MD, PhDTaking people
About the trial
What the trial wants to find out
Gout is the most frequent inflammatory arthritis in men after 40 years, with a prevalence of 0.9% in France. This disease is characterized by deposits of sodium urate crystals in joints, tendons and soft tissues, which can be detected by ultrasound examination. To date, there was no study assessing inflammatory, structural and deposit lesions due to gout in joints and tendons, since the standardization of ultrasound definitions of gout by the OMERACT (Outcome Measures in Rheumatology) in 2015. The objective of this study is t estimate the prevalence and severity of ultrasound inflammatory lesions (synovitis, tenosynovitis, soft tissues abnormalities), structural lesions (osteophytes, erosions) and abnormalities due to sodium urate deposits (double contour, aggregates, tophi) in patients with gout.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 19 March 2025